Hypertension in Pregnancy
By:
Laura A. MageeDepartment of Women and Children’s Health, School of Life Course Sciences, King’s College London, United Kingdom

Search for other papers by Laura A. Magee in
Current site
Google Scholar
PubMed
Close
and
Peter von DadelszenDepartment of Women and Children’s Health, School of Life Course Sciences, King’s College London, United Kingdom

Search for other papers by Peter von Dadelszen in
Current site
Google Scholar
PubMed
Close
  • Collapse
  • Expand
  • 1

    Bello NA, Miller E, Cleary K, Wapner R, Shimbo D, Tita AT: Out of office blood pressure measurement in pregnancy and the postpartum period. Curr Hypertens Rep 20: 101, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2

    Waugh JJ, Gupta M, Rushbrook J, Halligan A, Shennan AH: Hidden errors of aneroid sphygmomanometers. Blood Press Monit 7: 309312, 2002 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3

    STRIDEBP: STRIDE-BP: Validated BP monitors in pregnancy. Available at: https://stridebporg/bp=monitors. Accessed January 2, 2021

  • 4

    Scott G, Gillon TE, Pels A, von Dadelszen P, Magee LA: Guidelines-similarities and dissimilarities: A systematic review of international clinical practice guidelines for pregnancy hypertension. Am J Obstet Gynecol 226: S1222S1236, 2022 10.1016/j.ajog.2020.08.018PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5

    Reddy M, Rolnik DL, Harris K, Li W, Mol BW, Da Silva Costa F, et al.: Challenging the definition of hypertension in pregnancy: A retrospective cohort study. Am J Obstet Gynecol 222: 606.e1606.e21, 2020

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6

    Bone JN, Magee LA, Singer J, Nathan H, Qureshi RN, Sacoor C, et al.; CLIP study group: Blood pressure thresholds in pregnancy for identifying maternal and infant risk: A secondary analysis of Community-Level Interventions for Pre-eclampsia (CLIP) trial data. Lancet Glob Health 9: e1119e1128, 2021 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7

    Tucker KL, Hodgkinson J, Wilson HM, Crawford C, Stevens R, Lay-Flurrie S, et al.: Current prevalence of self-monitoring of blood pressure during pregnancy: The BUMP Survey. J Hypertens 39: 9941001, 2021 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8

    Tucker KL, Bankhead C, Hodgkinson J, Roberts N, Stevens R, Heneghan C, et al.: How do home and clinic blood pressure readings compare in pregnancy? Hypertension 72: 686694, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9

    Chappell LC, Tucker KL, Galal U, Yu LM, Campbell H, Rivero-Arias O, et al.; BUMP 2 Investigators: Effect of self-monitoring of blood pressure on blood pressure control in pregnant individuals with chronic or gestational hypertension: The BUMP 2 Randomized Clinical Trial. JAMA 327: 16661678, 2022 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10

    Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, et al.: The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens 27: 148169, 2022 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11

    Green CR, Blake JM, Carson GD, Po L, Brown ARH, Friedman CL: Choosing wisely: SOGC’s top 10 recommendations. J Obstet Gynaecol Can 40: 716722, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12

    Magee LA, Sharma S, Sevene E, Qureshi RN, Mallapur A, Macuácua SE, et al.; The Community-Level Interventions for Pre-eclampsia Study Group: Population-level data on antenatal screening for proteinuria; India, Mozambique, Nigeria, Pakistan. Bull World Health Organ 98: 661670, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13

    Waugh J, Hooper R, Lamb E, Robson S, Shennan A, Milne F, et al.: Spot protein-creatinine ratio and spot albumin-creatinine ratio in the assessment of pre-eclampsia: A diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis. Health Technol Assess 21: 190, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14

    von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton Pipkin F, Côté AM, et al.; PIERS Study Group: Prediction of adverse maternal outcomes in pre-eclampsia: Development and validation of the fullPIERS model. Lancet 377: 219227, 2011 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15

    Johnson S, Gordijn S, Damhuis S, Ganzevoort W, Brown M, von Dadelszen P, et al.; ISSHP: Diagnosis and monitoring of white coat hypertension in pregnancy: An ISSHP Consensus Delphi Procedure. Hypertension 79: 9931005, 2022 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16

    Brown MA, Mangos G, Davis G, Homer C: The natural history of white coat hypertension during pregnancy. BJOG 112: 601606, 2005 PubMed

  • 17

    Rodrigues Â, Barata C, Marques I, Almeida MC: Diagnosis of white coat hypertension and pregnancy outcomes. Pregnancy Hypertens 14: 121124, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18

    Stergiou GS, Kario K, Kollias A, McManus RJ, Ohkubo T, Parati G, et al.: Home blood pressure monitoring in the 21st century. J Clin Hypertens (Greenwich) 20: 11161121, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19

    Majak GB, Reisaeter AV, Zucknick M, Lorentzen B, Vangen S, Henriksen T, et al.: Preeclampsia in kidney transplanted women; Outcomes and a simple prognostic risk score system. PLoS One 12: e0173420, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20

    Bramham K, Parnell B, Nelson-Piercy C, Seed PT, Poston L, Chappell LC: Chronic hypertension and pregnancy outcomes: Systematic review and meta-analysis. BMJ 348: g2301, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21

    Hawkins L-AT, Brown MA, Mangos GJ, Davis GK: Transient gestational hypertension: Not always a benign event. Pregnancy Hypertens 2: 2227, 2012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22

    Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, et al.: Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 125: 911919, 2012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 23

    Chappell LC, Duckworth S, Seed PT, Griffin M, Myers J, Mackillop L, et al.: Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: A prospective multicenter study. Circulation 128: 21212131, 2013 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24

    Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennström M, et al.: Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med 374: 1322, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25

    Duhig KE, Myers J, Seed PT, Sparkes J, Lowe J, Hunter RM, et al.; PARROT trial group: Placental growth factor testing to assess women with suspected pre-eclampsia: A multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. Lancet 393: 18071818, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26

    Bian X, Biswas A, Huang X, Lee KJ, Li TK, Masuyama H, et al.: Short-term prediction of adverse outcomes using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) ratio in Asian women with suspected preeclampsia. Hypertension 74: 164172, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27

    Saudan P, Brown MA, Buddle ML, Jones M: Does gestational hypertension become pre-eclampsia? Br J Obstet Gynaecol 105: 11771184, 1998 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 28

    Garovic VD, White WM, Vaughan L, Saiki M, Parashuram S, Garcia-Valencia O, et al.: Incidence and long-term outcomes of hypertensive disorders of pregnancy. J Am Coll Cardiol 75: 23232334, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 29

    Magee LA, Nicolaides KH, von Dadelszen P: Preeclampsia. N Engl J Med 386: 18171832, 2022 PubMed

  • 30

    Homer CS, Brown MA, Mangos G, Davis GK: Non-proteinuric pre-eclampsia: A novel risk indicator in women with gestational hypertension. J Hypertens 26: 295302, 2008 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31

    Bramham K, Seed PT, Lightstone L, Nelson-Piercy C, Gill C, Webster P, et al.: Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. Kidney Int 89: 874885, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32

    Perni U, Sison C, Sharma V, Helseth G, Hawfield A, Suthanthiran M, et al.: Angiogenic factors in superimposed preeclampsia: A longitudinal study of women with chronic hypertension during pregnancy. Hypertension 59: 740746, 2012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 33

    National Guideline Alliance; Royal College of Obstetricians and Gynaecologists: Hypertension in pregnancy: [C] Evidence review for prediction of complications in pre-eclampsia. NICE guideline NG133, London, National Institute for Health and Care Excellence, 2019. Available at: https://www.nice.org.uk/guidance/ng133/evidence/c-prediction-of-complications-in-preeclampsia-pdf-6836186128. Accessed December 29, 2021

  • 34

    Lim S, Li W, Kemper J, Nguyen A, Mol B, Reddy M: Biomarkers and the prediction of adverse outcomes in preeclampsia: A systematic review and meta-analysis. Obstet Gynecol 137: 7281, 2021 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 35

    Rana S, Karumanchi SA, Lindheimer MD: Angiogenic factors in diagnosis, management, and research in preeclampsia. Hypertension 63: 198202, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 36

    Dröge LA, Perschel FH, Stütz N, Gafron A, Frank L, Busjahn A, et al.: Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-ratio in the clinical routine: A real-world study. Hypertension 77: 461471, 2021 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 37

    Townsend R, Khalil A, Premakumar Y, Allotey J, Snell KIE, Chan C, et al.; IPPIC Network: Prediction of pre-eclampsia: Review of reviews. Ultrasound Obstet Gynecol 54: 1627, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38

    Giannakou K, Evangelou E, Papatheodorou SI: Genetic and non-genetic risk factors for pre-eclampsia: Umbrella review of systematic reviews and meta-analyses of observational studies. Ultrasound Obstet Gynecol 51: 720730, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 39

    Yagel S, Cohen SM, Goldman-Wohl D: An integrated model of preeclampsia: A multifaceted syndrome of the maternal cardiovascular-placental-fetal array. Am J Obstet Gynecol 226: S963S972, 2022 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 40

    Wright D, Wright A, Nicolaides KH: The competing risk approach for prediction of preeclampsia. Am J Obstet Gynecol 223: 1223.e7, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 41

    Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al.; US Preventive Services Task Force: Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force Recommendation Statement. JAMA 326: 11861191, 2021 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 42

    Bartsch E, Medcalf KE, Park AL, Ray JG; High Risk of Pre-eclampsia Identification Group: Clinical risk factors for pre-eclampsia determined in early pregnancy: Systematic review and meta-analysis of large cohort studies. BMJ 353: i1753, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 43

    Zhang JJ, Ma XX, Hao L, Liu LJ, Lv JC, Zhang H: A systematic review and meta-analysis of outcomes of pregnancy in CKD and CKD outcomes in pregnancy. Clin J Am Soc Nephrol 10: 19641978, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 44

    Berntsen S, Söderström-Anttila V, Wennerholm UB, Laivuori H, Loft A, Oldereid NB, et al.: The health of children conceived by ART: ‘The chicken or the egg?’. Hum Reprod Update 25: 137158, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 45

    Poon LC, Rolnik DL, Tan MY, Delgado JL, Tsokaki T, Akolekar R, et al.: ASPRE trial: Incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm. Ultrasound Obstet Gynecol 51: 738742, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 46

    The Fetal Medicine Foundation: Risk for preeclampsia. Available at: https://fetalmedicine.org/research/assess/preeclampsia/first-trimester. Accessed December 29, 2020

  • 47

    Al-Rubaie Z, Askie LM, Ray JG, Hudson HM, Lord SJ: The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: A systematic review. BJOG 123: 14411452, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 48

    Wright A, Wright D, Syngelaki A, Georgantis A, Nicolaides KH: Two-stage screening for preterm preeclampsia at 11-13 weeks' gestation. Am J Obstet Gynecol 220: 197.e1197.e11, 2019

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 49

    Tong S, Kaitu’u-Lino TJ, Hastie R, Brownfoot F, Cluver C, Hannan N: Pravastatin, proton-pump inhibitors, metformin, micronutrients, and biologics: New horizons for the prevention or treatment of preeclampsia. Am J Obstet Gynecol 226: S1157S1170, 2022 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 50

    Dobert M, Wright A, Varouxaki AN, Mu AC, Syngelaki A, Rehal A, et al.: STATIN trial: Predictive performance of competing-risk model in screening for pre-eclampsia at 35-37 weeks’ gestation. Ultrasound Obstet Gynecol 59: 6975, 2022 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 51

    Wen SW, White RR, Rybak N, Gaudet LM, Robson S, Hague W, et al.; FACT Collaborating Group: Effect of high dose folic acid supplementation in pregnancy on pre-eclampsia (FACT): Double blind, phase III, randomised controlled, international, multicentre trial. BMJ 362: k3478, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 52

    Rodger MA, Gris JC, de Vries JIP, Martinelli I, Rey É, Schleussner E, et al.; Low-Molecular-Weight Heparin for Placenta-Mediated Pregnancy Complications Study Group: Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: A meta-analysis of individual patient data from randomised controlled trials. Lancet 388: 26292641, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 53

    Davenport MH, Ruchat SM, Poitras VJ, Jaramillo Garcia A, Gray CE, Barrowman N, et al.: Prenatal exercise for the prevention of gestational diabetes mellitus and hypertensive disorders of pregnancy: A systematic review and meta-analysis. Br J Sports Med 52: 13671375, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 54

    Mottola MF, Davenport MH, Ruchat SM, Davies GA, Poitras V, Gray C, et al.: No. 367-2019 Canadian Guideline for Physical Activity throughout Pregnancy. J Obstet Gynaecol Can 40: 15281537, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 55

    Kinshella MW, Sarr C, Sandhu A, Bone JN, Vidler M, Moore SE, et al.: Calcium for pre-eclampsia prevention: A systematic review and network meta-analysis to guide personalised antenatal care [published online ahead of print May 20, 2022]. BJOG 10.1111/1471-0528.17222

    • Search Google Scholar
    • Export Citation
  • 56

    Duley L, Meher S, Hunter KE, Seidler AL, Askie LM: Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2019: CD004659, 2019

    • Search Google Scholar
    • Export Citation
  • 57

    Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco Matallana C, et al.: Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med 377: 613622, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 58

    Ortved D, Hawkins TL, Johnson JA, Hyett J, Metcalfe A: Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia. Ultrasound Obstet Gynecol 53: 239244, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 59

    Shmueli A, Meiri H, Gonen R: Economic assessment of screening for pre-eclampsia. Prenat Diagn 32: 2938, 2012 PubMed

  • 60

    Roberge S, Bujold E, Nicolaides KH: Aspirin for the prevention of preterm and term preeclampsia: Systematic review and metaanalysis. Am J Obstet Gynecol 218: 287293.e1, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 61

    Rolnik DL, Nicolaides KH, Poon LC: Prevention of preeclampsia with aspirin. Am J Obstet Gynecol 226: S1108S1119, 2022 PubMed

  • 62

    Askie LM, Duley L, Henderson-Smart DJ, Stewart LA; PARIS Collaborative Group: Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data. Lancet 369: 17911798, 2007 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 63

    Werner EF, Hauspurg AK, Rouse DJ: A cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States. Obstet Gynecol 126: 12421250, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 64

    Mallampati D, Grobman W, Rouse DJ, Werner EF: Strategies for prescribing aspirin to prevent preeclampsia: A cost-effectiveness analysis. Obstet Gynecol 134: 537544, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 65

    Mone F, O’Mahony JF, Tyrrell E, Mulcahy C, McParland P, Breathnach F, et al.: Preeclampsia prevention using routine versus screening test-indicated aspirin in low-risk women. Hypertension 72: 13911396, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 66

    Hastie R, Tong S, Wikstrom AK, Sandstrom A, Hesselman S, Bergman L: Aspirin use during pregnancy and the risk of bleeding complications: A Swedish population-based cohort study. Am J Obstet Gynecol 224: 95.e195.e12, 2021 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 67

    Wright D, Nicolaides KH: Competing risks model for prediction of preeclampsia. Am J Obstet Gynecol 225: 205206, 2021 PubMed

  • 68

    CMQCC: Improving Health Care Response to Preeclampsia: A California Toolkit to Transform Maternity Care (California Maternal Quality Care Collaborative), 2014. Available at: https://wwwcmqccorg/resources-tool-kits/toolkits/preeclampsia-toolkit. Accessed December 29, 2021

  • 69

    Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, et al.; CHIPS Study Group: The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study): Is severe hypertension just an elevated blood pressure? Hypertension 68: 11531159, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 70

    Sridharan K, Sequeira RP: Drugs for treating severe hypertension in pregnancy: A network meta-analysis and trial sequential analysis of randomized clinical trials. Br J Clin Pharmacol 84: 19061916, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 71

    Alavifard S, Chase R, Janoudi G, Chaumont A, Lanes A, Walker M, et al.: First-line antihypertensive treatment for severe hypertension in pregnancy: A systematic review and network meta-analysis. Pregnancy Hypertens 18: 179187, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 72

    Easterling T, Mundle S, Bracken H, Parvekar S, Mool S, Magee LA, et al.: Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: An open-label, randomised controlled trial. Lancet 394: 10111021, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 73

    Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, et al.: Less-tight versus tight control of hypertension in pregnancy. N Engl J Med 372: 407417, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 74

    Abalos E, Duley L, Steyn DW, Gialdini C: Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 10: CD002252, 2018 PubMed

    • Search Google Scholar
    • Export Citation
  • 75

    Tita AT, Szychowski JM, Boggess K, Dugoff L, Sibai B, Lawrence K, et al.; Chronic Hypertension and Pregnancy (CHAP) Trial Consortium: Treatment for mild chronic hypertension during pregnancy. N Engl J Med 386: 17811792, 2022 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 76

    Magee LA, Khalil A, von Dadelszen P: Pregnancy hypertension diagnosis and care in COVID-19 era and beyond. Ultrasound Obstet Gynecol 56: 710, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 77

    Butalia S, Audibert F, Côté AM, Firoz T, Logan AG, Magee LA, et al.; Hypertension Canada: Hypertension Canada’s 2018 Guidelines for the Management of Hypertension in Pregnancy. Can J Cardiol 34: 526531, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 78

    Bone JN, Sandhu A, Abalos ED, Khalil A, Singer J, Prasad S, et al.: Oral antihypertensives for nonsevere pregnancy hypertension: Systematic review, network meta- and trial sequential analyses. Hypertension 79: 614628, 2022 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 79

    British Association of Perinatal Medicine: Identification and Management of Neonatal Hypoglycaemia in the Full Term Infant (2017): A BAPM Framework for Practice, 2017. Available at: https://www.bapm.org/resources/40-identification-and-management-of-neonatal-hypoglycaemia-in-the-full-term-infant-2017. Accessed December 29, 2021

  • 80

    Fitton CA, Steiner MFC, Aucott L, Pell JP, Mackay DF, Fleming M, et al.: In-utero exposure to antihypertensive medication and neonatal and child health outcomes: A systematic review. J Hypertens 35: 21232137, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 81

    Bateman BT, Huybrechts KF, Fischer MA, Seely EW, Ecker JL, Oberg AS, et al.: Chronic hypertension in pregnancy and the risk of congenital malformations: A cohort study. Am J Obstet Gynecol 212: 337.e1337.e14, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 82

    Weber-Schoendorfer C, Kayser A, Tissen-Diabaté T, Winterfeld U, Eleftheriou G, Te Winkel B, et al.: Fetotoxic risk of AT1 blockers exceeds that of angiotensin-converting enzyme inhibitors: An observational study. J Hypertens 38: 133141, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 83

    Fisher SC, Van Zutphen AR, Werler MM, Lin AE, Romitti PA, Druschel CM, et al.; National Birth Defects Prevention Study: Maternal antihypertensive medication use and congenital heart defects: Updated results from the National Birth Defects Prevention Study. Hypertension 69: 798805, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 84

    Bullo M, Tschumi S, Bucher BS, Bianchetti MG, Simonetti GD: Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: A systematic review. Hypertension 60: 444450, 2012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 85

    Thornton CE, von Dadelszen P, Makris A, Tooher JM, Ogle RF, Hennessy A: Acute pulmonary oedema as a complication of hypertension during pregnancy. Hypertens Pregnancy 30: 169179, 2011 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 86

    Nasab SH, Moussa HN, Alrais MA, Sibai BM, Baha M, Blackwell SC: Postpartum readmissions: What we can learn from numbers? Obstet Gynecol 131: 123S, 2018 10.097/01.AOG.0000533520.08596.85

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 87

    Malhamé I, Danilack VA, Raker CA, Hardy EJ, Spalding H, Bouvier BA, et al.: Cardiovascular severe maternal morbidity in pregnant and postpartum women: Development and internal validation of risk prediction models. BJOG 128: 922932, 2021 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 88

    Blue NR, Murray-Krezan C, Drake-Lavelle S, Weinberg D, Holbrook BD, Katukuri VR, et al.: Effect of ibuprofen vs acetaminophen on postpartum hypertension in preeclampsia with severe features: A double-masked, randomized controlled trial. Am J Obstet Gynecol 218: 616.e1616.e8, 2018

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 89

    Vigil-De Gracia P, Solis V, Ortega N: Ibuprofen versus acetaminophen as a post-partum analgesic for women with severe preeclampsia: Randomized clinical study. J Matern Fetal Neonatal Med 30: 12791282, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 90

    National Library of Medicine: Drugs and Lactation Database (LactMed), 2006. Available at: https://www.ncbi.nlm.nih.gov/books/NBK501922/?term=lactmed. Accessed December 29, 2021

  • 91

    Kitt JA, Fox RL, Cairns AE, Mollison J, Burchert HH, Kenworthy Y, et al.: Short-term postpartum blood pressure self-management and long-term blood pressure control: A randomized controlled trial. Hypertension 78: 469479, 2021 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 92

    van Oostwaard MF, Langenveld J, Schuit E, Papatsonis DN, Brown MA, Byaruhanga RN, et al.: Recurrence of hypertensive disorders of pregnancy: An individual patient data metaanalysis. Am J Obstet Gynecol 212: 624.e1624.e17, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 93

    Khosla K, Heimberger S, Nieman KM, Tung A, Shahul S, Staff AC, et al.: Long-term cardiovascular disease risk in women after hypertensive disorders of pregnancy: Recent advances in hypertension. Hypertension 78: 927935, 2021 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 94

    Markovitz AR, Stuart JJ, Horn J, Williams PL, Rimm EB, Missmer SA, et al.: Does pregnancy complication history improve cardiovascular disease risk prediction? Findings from the HUNT study in Norway. Eur Heart J 40: 11131120, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 95

    Cho L, Davis M, Elgendy I, Epps K, Lindley KJ, Mehta PK, et al.; ACC CVD Womens Committee Members: Summary of updated recommendations for primary prevention of cardiovascular disease in women: JACC State-of-the-Art Review. J Am Coll Cardiol 75: 26022618, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 96

    Ukah UV, Dayan N, Auger N, He S, Platt RW: Development and internal validation of a model predicting premature cardiovascular disease among women with hypertensive disorders of pregnancy: A population-based study in Quebec, Canada. J Am Heart Assoc 9: e017328, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 97

    Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, et al.: The hypertensive disorders of pregnancy: The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis and management recommendations for international practice. Pregnancy Hypertens 27: 148169, 2022

    • Crossref
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 267 267 146
Full Text Views 210 210 44
PDF Downloads 281 281 62